Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised …
P Fransson, P Nilsson, A Gunnlaugsson… - The Lancet …, 2021 - thelancet.com
Summary Background The HYPO-RT-PC trial compared conventionally fractionated
radiotherapy with ultra-hypofractionated radiotherapy in patients with localised prostate …
radiotherapy with ultra-hypofractionated radiotherapy in patients with localised prostate …
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 …
A Widmark, A Gunnlaugsson, L Beckman… - The Lancet, 2019 - thelancet.com
Background Hypofractionated radiotherapy for prostate cancer has gained increased
attention due to its proposed high radiation-fraction sensitivity. Recent reports from studies …
attention due to its proposed high radiation-fraction sensitivity. Recent reports from studies …
[HTML][HTML] Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient …
A Wilkins, H Mossop, I Syndikus, V Khoo… - The Lancet …, 2015 - thelancet.com
Summary Background Patient-reported outcomes (PROs) might detect more toxic effects of
radiotherapy than do clinician-reported outcomes. We did a quality of life (QoL) substudy to …
radiotherapy than do clinician-reported outcomes. We did a quality of life (QoL) substudy to …
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority …
S Aluwini, F Pos, E Schimmel, S Krol… - The Lancet …, 2016 - thelancet.com
Background Several studies have reported a low α to β ratio for prostate cancer, suggesting
that hypofractionation could enhance the biological tumour dose without increasing …
that hypofractionation could enhance the biological tumour dose without increasing …
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised …
L Incrocci, RC Wortel, WG Alemayehu… - The Lancet …, 2016 - thelancet.com
Background Studies have reported a low α/β ratio for prostate cancer, suggesting that
hypofractionation could enhance the biological tumour dose without increasing …
hypofractionation could enhance the biological tumour dose without increasing …
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority …
S Aluwini, F Pos, E Schimmel, E van Lin, S Krol… - The Lancet …, 2015 - thelancet.com
Background In 2007, we began the randomised phase 3 multicentre HYPRO trial to
investigate the effect of hypofractionated radiotherapy compared with conventionally …
investigate the effect of hypofractionated radiotherapy compared with conventionally …
[HTML][HTML] Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority …
D Dearnaley, I Syndikus, H Mossop, V Khoo… - The Lancet …, 2016 - thelancet.com
Background Prostate cancer might have high radiation-fraction sensitivity that would give a
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis …
Introduction To characterize the efficacy (5-year disease-free survival [DFS]) and safety
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
A systematic review of hypofractionation for primary management of prostate cancer
BF Koontz, A Bossi, C Cozzarini, T Wiegel, A D'Amico - European urology, 2015 - Elsevier
Context Technological advances in radiation therapy delivery have permitted the use of high-
dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 …
dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 …
Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
相关搜索
- rt pc prostate cancer
- radiation therapy prostate cancer
- hypofractionated radiotherapy prostate cancer
- hypofractionated radiotherapy intermediate risk
- intermediate risk prostate cancer
- meta analysis prostate cancer
- primary management prostate cancer
- high dose prostate cancer
- executive summary prostate cancer
- hypo rt prostate cancer